Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05169892
Other study ID # Aquablation in BPH
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 9, 2019
Est. completion date December 31, 2026

Study information

Verified date December 2021
Source Can-Am HIFU Inc.
Contact Dean Elterman
Phone 4166035800
Email dean.elterman@uhn.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.


Description:

Patients will be followed up for 3 years as standard of care.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date December 31, 2026
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Primary diagnosis of Benign Prostate Hypertrophy (BPH) - Male subjects of = 18 years of age - Candidate for Aquablation therapy as per clinical decision of Investigator - Willing and able to accurately complete questionnaires - Willing and able to provide signed and dated informed consent Exclusion Criteria: - Characteristics indicating a poor compliance with study protocol requirements. - Disease or other health condition that is not suitable for this study. - Unable or unwilling to provide signed informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Aquablation
Aquablation

Locations

Country Name City State
Canada Dean Elterman Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Can-Am HIFU Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximum flow rate (Q-max) Standard of care Baseline
Primary Post-Void Residual (PVR) volume Standard of care Baseline
Primary Maximum flow rate (Q-max) Standard of care 1 month after surgery
Primary Post-Void Residual (PVR) volume Standard of care 1 month after surgery
Primary Maximum flow rate (Q-max) Standard of care 3 months after surgery
Primary Post-Void Residual (PVR) volume Standard of care 3 months after surgery
Primary Maximum flow rate (Q-max) Standard of care 6 months after surgery
Primary Post-Void Residual (PVR) volume Standard of care 6 months after surgery
Primary Maximum flow rate (Q-max) Standard of care 12 months after surgery
Primary Post-Void Residual (PVR) volume Standard of care 12 months after surgery
Primary Maximum flow rate (Q-max) Standard of care 24 months after surgery
Primary Post-Void Residual (PVR) volume Standard of care 24 months after surgery
Primary Maximum flow rate (Q-max) Standard of care 36 months after surgery
Primary Post-Void Residual (PVR) volume Standard of care 36 months after surgery
Primary Prostate Volume Standard of care Baseline
Primary Prostate Volume Standard of care 12 months after surgery
Primary Questionnaires IPSS Baseline
Primary Questionnaires IPSS 1 month after surgery
Primary Questionnaires IPSS 3 months after surgery
Primary Questionnaires IPSS 6 months after surgery
Primary Questionnaires IPSS 12 months after surgery
Primary Questionnaires IPSS 24 months after surgery
Primary Questionnaires IPSS 36 months after surgery
Primary Adverse Events Adverse Events Baseline
Primary Adverse Events Adverse Events 1 day of Surgery
Primary Adverse Events Adverse Events 1 month after surgery
Primary Adverse Events Adverse Events 3 months after surgery
Primary Adverse Events Adverse Events 6 months after surgery
Primary Adverse Events Adverse Events 12 months after surgery
Primary Adverse Events Adverse Events 24 months after surgery
Primary Adverse Events Adverse Events 36 months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06397287 - PROM Project Urology
Completed NCT03572348 - VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures. N/A
Completed NCT03339609 - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children N/A
Active, not recruiting NCT01529658 - Renal Hypothermia During Partial Nephrectomy N/A
Completed NCT05082142 - Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP) Phase 4
Completed NCT03668262 - ED50 of Cis-atracurium for Laryngeal Mask Incubation in General Anesthesia
Recruiting NCT04763538 - Quality and Outcome Measurements of Urological Patients
Completed NCT05032287 - Medical Expulsive Therapy Post-SWL For Renal Stones N/A
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Active, not recruiting NCT03243682 - The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones N/A
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Recruiting NCT05201131 - Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
Recruiting NCT06187870 - Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Completed NCT03847909 - A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 Phase 2
Recruiting NCT04972890 - The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction Phase 2/Phase 3
Not yet recruiting NCT03258658 - Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures Phase 1
Terminated NCT02543645 - A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer Phase 1
Terminated NCT03843073 - Connected Catheter- Safety and Effectiveness Study N/A
Terminated NCT04826484 - Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel Phase 3
Terminated NCT04059159 - Connected Catheter - Safety and Effectiveness Study N/A